Neurotech to enter next phase of implant testing

LINCOLN – Biotechnology firm Neurotech Pharmaceuticals Inc. is ready to begin the next phases of testing on its NT-501 for the treatment of retinitis pigmentosa.…

Want More Free?

To access 2 more articles, please log in or register for free.

Registered users get access to a limited number of free articles every month.

Register Now

Already registered? Login to access more free articles.

- Advertisement -